Cannabinoids Offer Modest Pain Relief but Fall Short of First-Line Status, Review Concludes
Overall, cannabinoids provide modest, condition-specific analgesia and should be considered adjunctive rather than first-line options, reserved for patients unresponsive to conventional therapy.
What Pending Medical Cannabis and Hemp Legislation Means for Georgia | JD Supra
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyHempTHCCBD Why This Matters Georgia's proposed legislation to eliminate the 5% THC cap would allow…
First medical cannabis dispensary opening in Alabama in May – Yahoo
✦ New CED Clinical Relevance #84High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic AccessPolicyState ProgramsChronic…
Alabama medical cannabis sales to start in May – MJBizDaily
✦ New CED Clinical Relevance #84High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Medical CannabisState PolicyPatient…
Full-Spectrum Cannabis Extract Shows Significant Pain Reduction in Chronic Neuropathic Pain
If you live with chronic nerve pain, this study provides clinical evidence that full-spectrum cannabis extracts can deliver meaningful relief with fewer side effects than many conventional pain medications. A clinical study found that a full-spectrum…